$433 Million is the total value of New Leaf Venture Partners, L.L.C.'s 17 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS INC | $193,899,000 | +259.7% | 2,283,048 | 0.0% | 44.80% | +106.3% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $69,030,000 | +11.2% | 1,209,571 | 0.0% | 15.95% | -36.2% | |
| PASG | PASSAGE BIO | $63,872,000 | +95.0% | 2,497,922 | 0.0% | 14.76% | +11.8% | |
| HARP | HARPOON THERAPEUTICS INC | $48,525,000 | -2.2% | 2,921,405 | 0.0% | 11.21% | -43.9% | |
| APTX | APTINYX INC | $11,384,000 | +2.4% | 3,290,079 | 0.0% | 2.63% | -41.3% | |
| SRRA | SIERRA ONCOLOGY INC | $6,566,000 | +50.2% | 409,611 | 0.0% | 1.52% | -13.9% | |
| CMRX | CHIMERIX INC | $6,521,000 | +94.0% | 1,350,000 | 0.0% | 1.51% | +11.2% | |
| COGT | New | COGENT BIOSCIENCES INC. | $5,496,000 | – | 489,380 | +100.0% | 1.27% | – |
| ARAV | ARAVIVE INC | $5,338,000 | +20.0% | 946,423 | 0.0% | 1.23% | -31.2% | |
| ALEC | ALECTOR INC | $5,138,000 | +43.6% | 339,569 | 0.0% | 1.19% | -17.6% | |
| CHMA | CHIASMA INC | $4,940,000 | +1.1% | 1,135,700 | 0.0% | 1.14% | -42.0% | |
| AVRO | AVROBIO INC | $4,399,000 | +7.1% | 315,550 | 0.0% | 1.02% | -38.6% | |
| XFOR | X4 PHARMACEUTICALS INC | $2,154,000 | -5.0% | 335,000 | 0.0% | 0.50% | -45.5% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $1,990,000 | -9.9% | 141,000 | 0.0% | 0.46% | -48.3% | |
| OBSV | OBSEVA SA | $1,873,000 | -16.1% | 900,501 | 0.0% | 0.43% | -51.9% | |
| ITRM | ITERUM THERAPEUTICS PLC | $1,440,000 | -5.8% | 1,456,303 | 0.0% | 0.33% | -45.9% | |
| PDSB | PDS BIOTECHNOLOGY CORP | $251,000 | -8.1% | 117,242 | 0.0% | 0.06% | -47.3% | |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -449,500 | -100.0% | -0.58% | – |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -1,795,545 | -100.0% | -1.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.